OKTA vs SNTI · P/E 84, rev $1.57B vs rev $33.0K
Okta Inc (OKTA) versus Senti Biosciences Inc (SNTI) — a side-by-side from cached financials, not a winner call.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Senti Biosciences Inc (SNTI) is a biotechnology company listed on NASDAQ.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Latest reported SNTI revenue for 2026-06-30 was $33.0K. Net income was -$17.0M. SNTI currently screens at market cap $29.6M.
OKTA currently screens at market cap $20.06B and trailing P/E 83.6. SNTI currently screens at market cap $29.6M.
Not investment advice. Open the OKTA and SNTI stock pages for the full models.
Not investment advice.